Prostate cancer decisions — 2025

The Board denied the veteran's claim for special monthly compensation based on the need for regular aid and attendance or at the housebound rate. The decision was based on the lack of evidence showing that the service-connected disabilities rendered the veteran helpless enough to require regular aid and attendance.

The veteran is granted an initial rating of 40 percent for residuals from prostate cancer with voiding dysfunction. The claim for service connection for a heart condition, including atrial fibrillation with valvular heart disease and cardiomyopathy, is remanded.

The veteran's effective date for service connection of tinnitus and prostate cancer was moved to January 19, 2021. Other issues were remanded.

The veteran's claims for service connection for COPD, coronary artery disease, diabetes mellitus type II, residuals of prostate cancer, hypertension, and neuropathy of the lower extremities were denied. The claim for tinnitus was granted.

The Board denied service connection for prostate cancer because the evidence did not show a relationship between the Veteran's prostate cancer and his military service, including exposure to TCE.

The Board denied the veteran's appeal to restore his 100% disability rating for prostate cancer, confirming a 20% rating effective November 1, 2022.

The appeal is remanded to obtain missing VA treatment records and reassess the effective date for service-connected prostate cancer residuals.

The Board denied service connection for all claimed conditions, including hypertension, hypothyroidism, loss of vision in the left eye, prostate cancer, and metastatic bone cancer. The decision was based on a lack of evidence linking these conditions to military service.

The veteran's effective date for service connection of prostate cancer is granted as July 19, 2022.

The veteran's service connection for non-Hodgkin's lymphoma, prostate cancer, and diabetes mellitus is granted under the PACT Act due to presumed exposure to herbicide agents during service at a Royal Thai Airforce Base.

The appeal for service connection of prostate cancer is remanded. The Board needs more information on the Veteran's exposure to lead paint and its potential link to prostate cancer.

The veteran's service connection for several conditions, including prostate cancer and depression, was granted an effective date of September 13, 2021. Some rating evaluations were denied or granted at specific percentages.

The veteran's appeal for service connection of prostate cancer is granted under the PACT Act due to presumed exposure to burn pits during service in Kuwait and Iraq.

The veteran was granted a 60% rating for prostate cancer and TDIU, but denied an increased rating for PTSD. The veteran was also granted SMC based on being housebound.

The Board remanded the claim to obtain a medical opinion on whether the Veteran's service-connected prostate cancer contributed to his death.

The veteran's claim for erectile dysfunction and special monthly compensation was granted effective February 24, 2020. The appeals regarding proposed rating reductions were dismissed.

The Board remanded the veteran's claim for service connection of prostate cancer to verify exposure to Agent Orange at Chanute AFB, Illinois.

The veteran's claim for a higher rating for prostate cancer residuals was denied. The claims for a higher rating for adjustment disorder with anxiety and TDIU were remanded.

The Board dismissed claims for higher ratings for diabetic peripheral neuropathy and denied higher ratings for several other conditions. It remanded decisions on TDIU and an effective date for Dependents' Educational Assistance.

The Board denied the veteran's claims for a higher rating for erectile dysfunction and prostate cancer, and an earlier effective date for the increased rating of erectile dysfunction.